Altman, J.D., Moss, P.A., Goulder, P.J., Barouch, D.H., McHeyzer-Williams, M.G.,
Bell, J.I., McMichael, A.J., Davis, M.M., 1996. Phenotypic analysis of
antigen-specific T lymphocytes. Science 274, 94.
Arnaout, M.A., Dana, N., Melamed, J., Medicus, R., Colten, H.R., 1983. Low ionic
strength or chemical cross-linking of monomeric C3b increases its
binding affinity to the human complement C3b receptor. Immunology
48, 229.
Behrens, E.M., Sriram, U., Shivers, D.K., Gallucci, M., Ma, Z., Finkel, T.H.,
Gallucci, S., 2007. Complement receptor 3 ligation of dendritic cells
suppresses their stimulatory capacity. J. Immunol. 178, 6268.
Blanquet-Grossard, F., Thielens, N.M., Vendrely, C., Jamin, M., Arlaud, G.J.,
2005. Complement protein C1q recognizes a conformationally modified
form of the prion protein. Biochemistry 44, 4349.
Chen, C.B., Wallis, R., 2004. Two mechanisms for mannose-binding protein
modulation of the activity of its associated serine proteases. J. Biol. Chem.
279, 26058.
Cretin, F.C., Serra, V.A., Villiers, M.B., Laharie, A.M., Marche, P.N., Gabert, F.M.,
2007. C3b complexation diversifies naturally processed T cell epitopes.
Mol. Immunol. 44, 2893.
Dempsey, P.W., Allison, M.E., Akkaraju, S., Goodnow, C.C., Fearon, D.T., 1996.
C3d of complement as a molecular adjuvant: bridging innate and
acquired immunity. Science 271, 348.
Dodds, A.W., 1993. Small-scale preparation of complement components C3
and C4. Methods Enzymol. 223, 46.
Flinn, N.S., Quibell, M., Turnell, W.G., Monk, T.P., Ramjee, M.K., 2004. Novel
chemoselective linkage chemistry toward controlled loading of ligands
to proteins through in situ real-time quantification of conjugate
formation. Bioconjug. Chem. 15, 1010.
Gadjeva, M., Dodds, A.W., Taniguchi-Sidle, A., Willis, A.C., Isenman, D.E.,
Law, S.K., 1998. The covalent binding reaction of complement
component C3. J. Immunol. 161, 985.
Holers, V.M., 2000. Phenotypes of complement knockouts. Immunopharmacology
49, 125.
Howard, J.B., 1980. Methylamine reaction and denaturation-dependent
fragmentation of complement component 3. Comparison with alpha2-
macroglobulin. J. Biol. Chem. 255, 7082.
Isenman, D.E., Kells, D.I., Cooper, N.R., Muller-Eberhard, H.J., Pangburn, M.K.,
1981. Nucleophilic modification of human complement protein C3:
correlation of conformational changes with acquisition of C3b-like
functional properties. Biochemistry 20, 4458.
Janssen, B.J., Christodoulidou, A., McCarthy, A., Lambris, J.D., Gros, P., 2006.
Structure of C3b reveals conformational changes that underlie complement
activity. Nature 444, 213.
Janssen, B.J., Huizinga, E.G., Raaijmakers, H.C., Roos, A., Daha, M.R., Nilsson-
Ekdahl, K., Nilsson, B., Gros, P., 2005. Structures of complement
component C3 provide insights into the function and evolution of
immunity. Nature 437, 505.
Klein, M.A., Kaeser, P.S., Schwarz, P., Weyd, H., Xenarios, I., Zinkernagel, R.M.,
Carroll, M.C., Verbeek, J.S., Botto, M.,Walport, M.J., Molina, H., Kalinke, U.,
Acha-Orbea, H., Aguzzi, A., 2001. Complement facilitates early prion
pathogenesis. Nat. Med. 7, 488.
Mabbott, N.A., Bruce, M.E., Botto, M., Walport, M.J., Pepys, M.B., 2001.
Temporary depletion of complement component C3 or genetic deficiency
of C1q significantly delays onset of scrapie. Nat. Med. 7, 485.
Micklem, K.J., Sim, R.B., 1985. Isolation of complement-fragment-iC3bbinding
proteins by affinity chromatography. The identification of
p150,95 as an iC3b-binding protein. Biochem. J. 231, 233.
Mitchell, D.A., Kirby, L., Paulin, S.M., Villiers, C.L., Sim, R.B., 2007. Prion protein
activates and fixes complement directly via the classical pathway:
implications for the mechanism of scrapie agent propagation in
lymphoid tissue. Mol. Immunol. 44, 2997.
Parkes, C., DiScipio, R.G., Kerr, M.A., Prohaska, R., 1981. The separation of
functionally distinct forms of the third component of human complement
(C3). Biochem. J. 193, 963.
Pickering, M.C., Cook, H.T., Warren, J., Bygrave, A.E., Moss, J., Walport, M.J.,
Botto, M., 2002. Uncontrolled C3 activation causes membranoproliferative
glomerulonephritis in mice deficient in complement factor H. Nat.
Genet. 31, 424.
Rozis, G., de Silva, S., Benlahrech, A., Papagatsias, T., Harris, J., Gotch, F.,
Dickson, G., Patterson, S., 2005. Langerhans cells are more efficiently
transduced than dermal dendritic cells by adenovirus vectors expressing
either group C or group B fibre protein: implications for mucosal
vaccines. Eur. J. Immunol. 35, 2617.
Seya, T., Holers, V.M., Atkinson, J.P., 1985. Purification and functional analysis
of the polymorphic variants of the C3b/C4b receptor (CR1) and
comparison with H, C4b-binding protein (C4bp), and decay accelerating
factor (DAF). J. Immunol. 135, 2661.
Sim, R.B., Sim, E., 1981. Autolytic fragmentation of complement components
C3 and C4 under denaturing conditions, a property shared with alpha 2-
macroglobulin. Biochem. J. 193, 129.
Ueda, T., Rieu, P., Brayer, J., Arnaout, M.A., 1994. Identification of the
complement iC3b binding site in the beta 2 integrin CR3 (CD11b/
CD18). Proc. Natl. Acad. Sci. U. S. A. 91, 10680.
Villiers, M.B., Villiers, C.L., Laharie, A.M., Marche, P.N., 1999. Amplification of
the antibody response by C3b complexed to antigen through an ester
link. J. Immunol. 162, 3647.
Walport, M.J., 2001a. Complement. First of two parts. N. Engl. J. Med. 344,
1058.
Walport, M.J., 2001b. Complement. Second of two parts. N. Engl. J. Med. 344,
1140.
Zabel, M.D., Weis, J.H., 2001. Cell-specific regulation of the CD21 gene. Int.
Immunopharmacol. 1, 483.